3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Patient Satisfaction
2
Urologic Neoplasms
1
Thyroid Cancer, Papillary
1
Sarcoma, Ewing
1
Sarcoma
1
Radiation Injuries
1
Patient Preference
1
Patient Acceptance of Health Care
1
Osteosarcoma
1
Osteitis Deformans
1
Neoplasms
1
Breast Neoplasms
1
Bone Neoplasms
1
Interventions
Radiotherapy
24
Radiotherapy, Intensity-Modulated
8
Radiosurgery
6
Amifostine
5
Low-Level Light Therapy
4
Donepezil
4
Cisplatin
4
Carboplatin
4
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Paclitaxel
3
Neuropsychological Tests
3
Heavy Ion Radiotherapy
3
Etoposide
3
Chemotherapy, Adjuvant
3
Chemoradiotherapy
3
Brachytherapy
3
Bevacizumab
3
Surgical Procedures, Operative
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Mental Status and Dementia Tests
2
Esophagectomy
2
Androgen Antagonists
2
Adrenal Cortex Hormones
2
sodium propionate
1
sargramostim
1
olaparib
1
endostar protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Radiation Injuries
×
delta 24-sterol reductase
×
Clear all
NCT04590976
2023-02-08
IP5-MATTER
Imperial College London
Completed
320 enrolled